Vitamin D deficiency predicts decline in kidney allograft function: A prospective cohort study

Abstract

Context: Vitamin D, often deficient in kidney transplant (KTx) recipients, has potential immunomodulatory effects. Objective: This study aimed to evaluate whether vitamin D status affects the rate of decline in kidney allograft function. Design, Setting, and Patients: The study included a prospective cohort of 264 ambulatory KTx recipients at a single Japanese center. Main Outcome Measures: We measured the baseline 25-hydroxyvitamin D (25D) concentration and examined its association with annual decline in estimated glomerular filtration rate (eGFR). Secondary outcome was rescue treatment with iv methylprednisolone (IV-MP) as an index of rejection episodes. Results: The mean serum 25D concentration was 17.1 (SD 6.5) ng/mL, and 68.4% patients had vitamin D inadequacy or deficiency. Time after KTx was a significant effect modifier for the association of serum 25D concentration with annual eGFR change and need for IV-MP (P for interaction < .1). We divided patients according to the median time after KTx (10 y) and found that low vitamin D was significantly associated with a rapid eGFR decline at less than 10 years after KTx but not at 10 or more years after KTx. The same was true for rescue treatment with IV-MP. Overall, propensity score matchingshowedindependent associations of low vitaminDwith both outcomes. Stratified matching confirmed pronounced associations at less than 10 years after KTx. Conclusions: Vitamin D deficiency predicts a rapid decline in eGFR and need for IV-MP at less than 10 years after KTx. Future studies are warranted to evaluate the clinical efficacy of vitamin D supplementation. Copyright © 2014 by the Endocrine Society.